-
Recent Posts
Pages
Recent Comments
-
Recent Posts
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Archives
Category Archives: FDA
“You’re telling me this now?” Why the news is suddenly critical of statins and antidepressants
Opinion: February 19, 2012 By Steven Greer, MD The CBS news show “60 Minutes” made waves with a story asserting that the antidepressants
The Lotus TAVR valve recall
March 16, 2017- produced and interviewed by Steven E. Greer, MD We interviewed William O’Neill, MD, one of the first to implant a Transcatheter Aortic Valve Replacement
Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA
Leave a comment
FDA CDER Director on Benlysta for lupus and adaptive clinical trials.
July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,
Posted in - Biotech, - Pharma, FDA, Rheumatology
Leave a comment
Is President Trump on amphetamines? (Yes, he is)
Update January 16, 2018- by Steven E. Greer, MD President Trump’s doctor confirms my diagnosis made in the story below, which was that the slurred
Posted in - Opinion, - Pharma, - Policy, FDA, Internal Medicine, Neurology, Primary care medicine, Rehab
Leave a comment
NBC begins alarming new series to promote the diagnosis of “mental illness” in children
December 11, 2017
Posted in - Opinion, - Pharma, - Policy, CDC, Congress, FDA, Neurology, Neurosurgery, NIH, Pediatrics, Primary care medicine, Psychology Psychiatry, Rehab
Leave a comment
Oh my god, I have a disease!
March 21, 2014- This DTC TV drug ad medicalizing a non-disease really struck us as egregious
Posted in - Pharma, Congress, FDA
Leave a comment
Hormone replacement therapy is safe and effective after all
November 14, 2017- Interviewed by Steven E. Greer, MD We interviewed JoAnn Manson, MD, DrPH about her JAMA paper that followed the cohorts in
The serious adverse events caused by antipsychotics
February 1, 2014
Posted in - Pharma, FDA
Leave a comment
The super shady methods of pricing generic drugs in America: case study- Sildenafil
May 15, 2016- by Steven E. Greer, MD The last I read, Teva and Mylan were not supposed to launch their approved generic of Viagra (sildenafil)
Posted in - Generics, - Opinion, - Pharma, CMS, Congress, FDA
Leave a comment
CDER Director Janet Woodcock on new drug safety strategies
November 16, 2010- by Steven E. Greer, MD We interviewed Dr. Janet Woodcock, long-time Director of CDER, the FDA center responsible
Posted in - Pharma, FDA
Leave a comment
The 23andMe home genetics test kit controversy
December 19, 2013- Interviewed by Steven E. Greer, MD
Posted in Columbia, FDA, Genetics, NIH, Oncology, Psychology Psychiatry
Leave a comment
Interview with the CEO of Neovasc, Alexei Marko
Posted in - Medical Devices, Cardiology, FDA
Leave a comment
Early stoppage of clinical trials
April 16, 2009– Dr. Guyatt explained in a previous post why early stoppage of clinical trials results
Posted in Cardiac surgery, FDA, McMaster University
Leave a comment
CBS News Promotes More Pro-Coffee Junk Science
July 11, 2017- by Steven E. Greer, MD How does one become a successful TV medical doctor pundit? First, you have to leave your medical ethics
Posted in - Opinion, Cardiology, CDC, Congress, Cornell, FDA, Primary care medicine, Psychology Psychiatry
Leave a comment
The Biggest Healthcare Stories of 2016
December 26, 2016- by Steven E. Greer, MD for The Healthcare Channel Policy changes dominated the 2016 year in healthcare news. There were few important new drug
Posted in - Biotech, - Generics, - Medical Devices, - Opinion, - Pharma, - Policy, - The Weekly Summary, CMS, FDA
Leave a comment
Robert De Niro gives credibility to vaccine truthers
Update March 27, 2016- Less than 24-hours after our story, this film has been pulled from the lineup. It was our story that got the heads of
Posted in - Pharma, - Reviews, books, devices, CDC, FDA, NIH, Pediatrics, Primary care medicine
Leave a comment
Man who oversaw one of the biggest academic research frauds in medical history is poised to become the next FDA Commissioner
Update February 7, 2016- Key senators, including Bernie Sanders, are now threatening to filibuster
Posted in - Opinion, - Policy, Cardiology, FDA, NIH
Leave a comment
Are the new PCSK9 cholesterol lowering drugs worth the high cost?
December 16, 2015- Interviewed by Steven E. Greer, MD
Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA
Leave a comment
Martin Shkreli, CEO of Turing Pharmaceuticals, could be the Bernie Madoff of the drug industry
September 22, 2015- by Steven E. Greer, MD Making national news today was Martin Shkreli, the baby-faced, greasy-haired, disheveled-looking
Posted in - Biotech, - Pharma, Congress, FDA
Leave a comment
Stephen Colbert mocks the new “female viagra” flibanserin
September 20, 2015- Well, the real CBS news did an atrocious job covering this story, so the fake newsman